How a small biotech firm is making big play to treat eye diseases


The company, which incorporated last year, has recently moved into a wet-lab space on a floor of Bridgeside Point on Technology Drive in Pittsburgh.

Previous After $2 billion deal, CEO lands at another biotech whose longtime boss is leaving
Next Spend Saturday experiencing life at The Reserve at Green Valley Ranch